Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianzhu Capsule
- Development stage
- Unknown
- Lead developer
- Lianyungang Kanion
- Administration
- Oral
01
Overview
Tianzhu Capsule is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Changchun Leiyunshang Pharmaceutical. It is administered orally in capsule form and is categorized as an anti-tumor medication within the company's product portfolio. Like many TCM products, it is composed of multiple herbal ingredients intended to work synergistically, and it does not have a single defined molecular mechanism of action. It is currently approved and marketed in China for oncological indications, often used alongside other treatments in the company's anti-cancer line such as Brucea javanica oil and Tianfoshen oral liquid.
- Brand names
- Tianzhu Capsule
- Other names
- 天珠胶囊Tianzhu Jiaonang
Beyond the preview
Go deeper on Tianzhu Capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tianzhu Capsule.